Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
7.56 USD | -2.45% | -5.07% | -13.31% |
May. 22 | Clarify Pharma confirms name change to File Forge | AN |
May. 09 | Transcript : COMPASS Pathways plc - Shareholder/Analyst Call |
Valuation
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Capitalization 1 | 1,712 | 922.3 | 341.9 | 541.6 | 529.7 | - | - |
Enterprise Value (EV) 1 | 1,521 | 649 | 198.7 | 350.2 | 232.7 | 266.8 | 331.5 |
P/E ratio | -13.4 x | -12.3 x | -3.72 x | -3.77 x | -3.51 x | -3.73 x | -3.43 x |
Yield | - | - | - | - | - | - | - |
Capitalization / Revenue | - | - | - | - | - | - | 16.2 x |
EV / Revenue | - | - | - | - | - | - | 10.1 x |
EV / EBITDA | -29.7 x | -7.82 x | -1.81 x | -2.56 x | -1.55 x | -1.66 x | -1.68 x |
EV / FCF | -36.7 x | -9.53 x | -1.87 x | -3.59 x | -2.13 x | -2.05 x | -2.03 x |
FCF Yield | -2.73% | -10.5% | -53.4% | -27.8% | -46.8% | -48.9% | -49.2% |
Price to Book | 8.71 x | 3.27 x | 1.89 x | 1.98 x | 2.24 x | 2.6 x | 3.93 x |
Nbr of stocks (in thousands) | 35,930 | 41,731 | 42,577 | 61,897 | 68,343 | - | - |
Reference price 2 | 47.64 | 22.10 | 8.030 | 8.750 | 7.750 | 7.750 | 7.750 |
Announcement Date | 3/9/21 | 2/24/22 | 2/28/23 | 2/29/24 | - | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net sales 1 | - | - | - | - | - | - | - | 32.74 |
EBITDA 1 | - | -51.28 | -83.05 | -110.1 | -136.7 | -150.6 | -160.4 | -197.1 |
EBIT 1 | -21.18 | -51.39 | -83.22 | -110.4 | -136.9 | -158 | -171.9 | -196.8 |
Operating Margin | - | - | - | - | - | - | - | -600.99% |
Earnings before Tax (EBT) 1 | - | -60.3 | -71.54 | -91.1 | -117.7 | -144.9 | -164 | -188.7 |
Net income 1 | - | -60.33 | -71.74 | -91.5 | -118.5 | -145.1 | -164 | -188.7 |
Net margin | - | - | - | - | - | - | - | -576.45% |
EPS 2 | -0.3500 | -3.550 | -1.790 | -2.160 | -2.320 | -2.206 | -2.080 | -2.262 |
Free Cash Flow 1 | - | -41.51 | -68.08 | -106 | -97.44 | -109 | -130.4 | -163.1 |
FCF margin | - | - | - | - | - | - | - | -498.19% |
FCF Conversion (EBITDA) | - | - | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - | - | - |
Announcement Date | 7/2/20 | 3/9/21 | 2/24/22 | 2/28/23 | 2/29/24 | - | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales 1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA 1 | -28.27 | -25.37 | -27.16 | -25.45 | -32.1 | -31.74 | -32.55 | -33.88 | -38.51 | - | -34.9 | -35.15 | -35.65 | - | - |
EBIT 1 | -28.32 | -25.42 | -27.26 | -25.54 | -32.19 | -31.79 | -32.66 | -34.06 | -38.4 | -38.57 | -38.58 | -39.79 | -40.16 | -43 | -45 |
Operating Margin | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Earnings before Tax (EBT) 1 | -25.55 | -21.03 | -20.98 | -18.25 | -30.83 | -24.08 | -28.14 | -33.33 | -32.14 | -34.96 | -35.67 | -36.86 | -37.07 | -44 | -46 |
Net income 1 | -25.65 | -21.17 | -21.04 | -18.37 | -30.93 | -24.21 | -28.34 | -33.39 | -32.53 | -35.19 | -35.67 | -36.86 | -37.07 | -44 | -46 |
Net margin | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EPS 2 | -0.6100 | -0.5000 | -0.5000 | -0.4300 | -0.7300 | -0.5700 | -0.6200 | -0.6700 | -0.5300 | -0.5500 | -0.5214 | -0.5357 | -0.5271 | -0.5300 | -0.4500 |
Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Announcement Date | 2/24/22 | 5/10/22 | 8/4/22 | 11/3/22 | 2/28/23 | 5/11/23 | 8/3/23 | 11/2/23 | 2/29/24 | 5/8/24 | - | - | - | - | - |
Balance Sheet Analysis
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Net Debt 1 | - | - | - | - | - | - | - |
Net Cash position 1 | 190 | 273 | 143 | 191 | 297 | 263 | 198 |
Leverage (Debt/EBITDA) | - | - | - | - | - | - | - |
Free Cash Flow 1 | -41.5 | -68.1 | -106 | -97.4 | -109 | -130 | -163 |
ROE (net income / shareholders' equity) | -72.6% | -29.8% | -39.3% | -58.2% | -60.9% | -73.1% | -118% |
ROA (Net income/ Total Assets) | - | - | - | -50.1% | - | - | - |
Assets 1 | - | - | - | 236.6 | - | - | - |
Book Value Per Share 2 | 5.470 | 6.770 | 4.250 | 4.420 | 3.470 | 2.990 | 1.970 |
Cash Flow per Share 2 | -2.440 | -1.690 | -2.480 | -1.570 | -1.440 | -1.670 | -2.230 |
Capex 1 | 0.13 | 0.33 | 0.6 | 0.07 | 4.15 | 8 | 15 |
Capex / Sales | - | - | - | - | - | - | 45.82% |
Announcement Date | 3/9/21 | 2/24/22 | 2/28/23 | 2/29/24 | - | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.31% | 530M | |
+65.17% | 62.59B | |
-1.48% | 41.18B | |
+44.76% | 40.29B | |
-8.93% | 27.9B | |
+13.40% | 26.21B | |
-21.78% | 19.09B | |
+4.90% | 13.08B | |
+25.47% | 12.26B | |
+28.61% | 12.05B |
- Stock Market
- Equities
- CMPS Stock
- Financials COMPASS Pathways plc